Royal Bank of Canada’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
495,311
+493,849
| +33,779% | +$1.14M | ﹤0.01% | 3471 |
|
|
2025
Q1 | $2K | Sell |
1,462
-5,073
| -78% | -$6.94K | ﹤0.01% | 6212 |
|
|
2024
Q4 | $11K | Sell |
6,535
-29,805
| -82% | -$50.2K | ﹤0.01% | 5836 |
|
|
2024
Q3 | $72K | Buy |
36,340
+20,644
| +132% | +$40.9K | ﹤0.01% | 5071 |
|
|
2024
Q2 | $35K | Buy |
+15,696
| New | +$35K | ﹤0.01% | 5437 |
|
|
2023
Q4 | – | Sell |
-19
| Closed | – | – | 6962 |
|
|
2023
Q3 | $0 | Sell |
19
-131
| -87% | – | ﹤0.01% | 7005 |
|
|
2023
Q2 | $0 | Buy |
150
+128
| +582% | – | ﹤0.01% | 7113 |
|
|
2023
Q1 | $0 | Sell |
22
-2
| -8% | – | ﹤0.01% | 6943 |
|
|
2022
Q4 | $0 | Buy |
24
+5
| +26% | – | ﹤0.01% | 7161 |
|
|
2022
Q3 | $0 | Sell |
19
-1,000
| -98% | – | ﹤0.01% | 7291 |
|
|
2022
Q2 | $4K | Sell |
1,019
-1,392
| -58% | -$5.46K | ﹤0.01% | 6295 |
|
|
2022
Q1 | $16K | Sell |
2,411
-2,204
| -48% | -$14.6K | ﹤0.01% | 6240 |
|
|
2021
Q4 | $53K | Buy |
4,615
+2,598
| +129% | +$29.8K | ﹤0.01% | 5815 |
|
|
2021
Q3 | $38K | Buy |
2,017
+485
| +32% | +$9.14K | ﹤0.01% | 5804 |
|
|
2021
Q2 | $32K | Buy |
1,532
+657
| +75% | +$13.7K | ﹤0.01% | 5810 |
|
|
2021
Q1 | $18K | Buy |
875
+406
| +87% | +$8.35K | ﹤0.01% | 5988 |
|
|
2020
Q4 | $12K | Buy |
+469
| New | +$12K | ﹤0.01% | 5750 |
|